Funding · Company
Noveome Biotherapeutics, Inc.
Pittsburgh, PABiotech & Pharma
Noveome Biotherapeutics, Inc. of Pittsburgh, PA has disclosed $36M across 1 Form D offering filed with the SEC on Aug 8, 2024.
$36M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$36M
Form D · Aug 8, 2024 ↗
Q3 2024
· 1 amendment, first filed Aug 17, 2023
· target $51M
Filing details
HeadquartersPittsburgh, PAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001478304Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →